Provided by Tiger Trade Technology Pte. Ltd.

SIMCERE PHARMA

11.100
-0.200-1.77%
Volume:7.70M
Turnover:85.51M
Market Cap:28.50B
PE:17.62
High:11.350
Open:11.310
Low:11.020
Close:11.300
52wk High:14.247
52wk Low:9.070
Shares:2.57B
HK Float Shares:2.57B
Volume Ratio:1.46
T/O Rate:0.30%
Dividend:0.21
Dividend Rate:1.86%
EPS(LYR):0.630
ROE:18.77%
ROA:7.78%
PB:2.59
PE(LYR):17.62
PS:2.80

Loading ...

Simcere Pharma Sets Board Meeting to Review Interim Results, Consider Dividend

Reuters
·
Aug 10

Simcere Pharmaceutical Group (SEHK:2096) Guidance Puts Valuation Back In Focus

Simply Wall St.
·
Aug 10

Simcere Pharmaceutical Expects 1H 2026 Revenue of Rmb4,550 Million-RMB4,610 Million

Reuters
·
Jul 30

Simcere Expects 1H Revenue up 27%-29% to RMB 4.55-4.61 Billion

Reuters
·
Jul 30

Simcere Pharma issues profit alert: 1H 2026 revenue to rise nearly 29 %, net profit up to RMB 860 million

Bulletin Express
·
Jul 30

Simcere Pharmaceutical - Expects 1H 2026 Revenue of Rmb4,550 Mln-RMB4,610 Mln, up 26.9%-28.6%

THOMSON REUTERS
·
Jul 30

Simcere Pharmaceutical - Sees Profit Attributable Rmb810 Mln to Rmb860 Mln for 1H 2026

THOMSON REUTERS
·
Jul 30

Movement Alert|SIMCERE PHARMA Falls 5.29% in Regular Trading, Trading at 12.2 HKD

Market Focus
·
Jul 30

Strategic AI Partnership Fuels Innovation and Pipeline Expansion for SIMCERE PHARMA

Stock News
·
Jul 15

SIMCERE PHARMA Partners with Global AI Drug Design Leader Schrödinger, Leveraging Dual "Physics+AI" Tech to Reshape Innovative Drug Pipeline Valuation

Stock News
·
Jul 10

Simcere Pharma's Acute Ischemic Stroke Included in National Essential Medicines List

MT Newswires Live
·
Jul 09

Simcere Pharma’s SANBEXIN® Added to China’s 2026 National Essential Medicines List

Bulletin Express
·
Jul 09

SIMCERE PHARMA's Novel Stroke Treatment Included in National Essential Medicines List

Stock News
·
Jul 09

Simcere Sanbexin Added to China 2026 National Essential Medicines List

Reuters
·
Jul 09

Simcere Pharmaceutical - Sanbexin Included in 2026 National Essential Medicines List

THOMSON REUTERS
·
Jul 09

Simcere Pharma Cancels 27.50 Million Repurchased Shares, Cutting Share Base by 1.06%

Bulletin Express
·
Jul 06

Hong Kong Innovative Drug Stocks Jump With HAIXI PHARMA and INNOCARE up 7%; KEYMED up 5%, REMEGEN up 4%

Tiger Newspress
·
Jul 06

SIMCERE PHARMA Shares Surge in Morning Trading Following Research Agreement and Bullish Analyst Target

Deep News
·
Jul 02

SIMCERE PHARMA Shares Surge Again, Nearing 9% Gain on Strong Analyst Backing and Impressive Financial Results

Stock News
·
Jul 02

SIMCERE PHARMA Shares Surge Nearly 8% in Afternoon Trading Following Research Collaboration Agreement with Stanford Medicine

Deep News
·
Jun 29